Immunogen (IMGN)

Add to Watchlists Create an Alert
17.74 +0.71  +4.17%   NASDAQ May 23, 4:59PM BATS Real time Currency in USD

Immunogen Revenue Quarterly YoY Growth:

668.8% for March 31, 2013
View Full Chart

Immunogen Revenue Quarterly YoY Growth Chart

    Immunogen Historical Revenue Quarterly YoY Growth Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 2   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    March 31, 2013 668.8%
    Dec. 31, 2012 -65.71%
    Sept. 30, 2012 61.32%
    June 30, 2012 -54.62%
    March 31, 2012 -37.59%
    Dec. 31, 2011 82.31%
    Sept. 30, 2011 -25.65%
    June 30, 2011 47.11%
    March 31, 2011 57.24%
    Dec. 31, 2010 34.43%
    Sept. 30, 2010 10.07%
    June 30, 2010 2.79%
    March 31, 2010 -59.71%
    Dec. 31, 2009 -66.70%
    Sept. 30, 2009 -49.41%
    June 30, 2009 -4.04%
    March 31, 2009 -43.62%
    Dec. 31, 2008 -4.28%
    Sept. 30, 2008 -46.38%
    June 30, 2008 -47.47%
    March 31, 2008 Go Pro
    Dec. 31, 2007 Go Pro
    Sept. 30, 2007 Go Pro
    June 30, 2007 Go Pro
    March 31, 2007 Go Pro
       
    Dec. 31, 2006 Go Pro
    Sept. 30, 2006 Go Pro
    June 30, 2006 Go Pro
    March 31, 2006 Go Pro
    Dec. 31, 2005 Go Pro
    Sept. 30, 2005 Go Pro
    June 30, 2005 Go Pro
    March 31, 2005 Go Pro
    Dec. 31, 2004 Go Pro
    Sept. 30, 2004 Go Pro
    June 30, 2004 Go Pro
    March 31, 2004 Go Pro
    Dec. 31, 2003 Go Pro
    Sept. 30, 2003 Go Pro
    June 30, 2003 Go Pro
    March 31, 2003 Go Pro
    Dec. 31, 2002 Go Pro
    Sept. 30, 2002 Go Pro
    June 30, 2002 Go Pro
    March 31, 2002 Go Pro
    Dec. 31, 2001 Go Pro
    Sept. 30, 2001 Go Pro
    June 30, 2001 Go Pro
    March 31, 2001 Go Pro
    Dec. 31, 2000 Go Pro

    About Revenue Growth

    Revenue growth illustrates sales increases/decreases over time. It is used to measure how fast a business is expanding. More valuable than a snapshot of revenue, revenue growth helps investors identify trends in order to gauge revenue growth over time.

    If a company generated $75 billion in revenue during 2008 and $100 billion in revenue during 2009, the company experienced roughly a ($100 billion/$75 billion)-1 = %33 increase in revenue.
    Learn More

    Get data for

    IMGN Revenue Quarterly YoY Growth Benchmarks

    Companies
    Merrimack Pharmaceuticals 12.83%
    Threshold Pharmaceuticals 1060%
    Seattle Genetics 30.73%

    IMGN Revenue Quarterly YoY Growth Rankings

    Overall 99th percentile
    39 of 8006
    Sector 97th percentile
    15 of 686 in Healthcare
    Industry 96th percentile
    9 of 248 in Biotechnology

    IMGN Revenue Quarterly YoY Growth Range, Past 5 Years

    Minimum -66.70% Dec 2009
    Maximum 668.8% Mar 2013
    Average 22.94%